Protara Therapeutics, Inc. (TARA) Operating cash flow 2016–2025
Protara Therapeutics, Inc. (TARA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$56.4MFY2025 · since FY2016: -$23.7M → -$56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.4M | -57.4% |
| FY2024 | -$35.8M | +4.7% |
| FY2023 | -$37.6M | -42.0% |
| FY2022 | -$26.5M | +23.3% |
| FY2021 | -$34.5M | -47.4% |
| FY2020 | -$23.4M | -367.1% |
| FY2019 | -$5.0M | +78.4% |
| FY2018 | -$23.2M | -3.9% |
| FY2017 | -$22.4M | +5.6% |
| FY2016 | -$23.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TARA financial trends
TARA RevenueTARA Net incomeTARA Net marginTARA Gross profitTARA Gross marginTARA Operating incomeTARA Operating marginTARA Free cash flowTARA Capital expendituresTARA Return on equityTARA Stock buybacksTARA Dividends paidTARA Total assetsTARA Total liabilitiesTARA Shareholders’ equityTARA overview →